Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-18

Clinical Trial Update: Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on dexamethasone therapy for adults with idiopathic thrombocytopenic purpura (ITP) reported in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: ITP, Croticosteroid Therapy | Phase 2, Phase 3 | Status: COMPLETED